Sinai Intellectual Cedars - Mar 8, 2023 Form 4 Insider Report for Prometheus Biosciences, Inc. (RXDX)

Role
10%+ Owner
Signature
/s/ Timothy K. Andrews, attorney-in-fact
Stock symbol
RXDX
Transactions as of
Mar 8, 2023
Transactions value $
-$99,120,350
Form type
4
Date filed
3/8/2023, 08:30 PM
Previous filing
Apr 5, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RXDX Common Stock Sale -$99.1M -865K -17.78% $114.59 4M Mar 8, 2023 See Footnote F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sinai Intellectual Cedars is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id Content
F1 The securities reported herein are held of record by Cedars Sinai Intellectual Property Company, which is a wholly owned subsidiary of Cedars-Sinai Medical Center.